• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Herd immunity against new influenza A (H1N1) in pre-vaccinated residents aged over 5 years in Beijing

tetano

Editor, Senior Moderator
Zhonghua Jie He He Hu Xi Za Zhi. 2010 Jun;33(6):403-405.
[Herd immunity against new influenza A (H1N1) in pre-vaccinated residents aged over 5 years in Beijing.]

[Article in Chinese]

Lu L, Liu DL, Zhang TG, Chen M, Zhang ZJ, Wang XL, Yang Z, Pang XH, Deng Y.

Department of Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing 100013, China.
Abstract

OBJECTIVE: To explore the herd immunity against influenza A (H1N1) in pre-vaccinated residents aged over 5 years, and therefore to provide data for vaccination policies in high risk populations.

METHODS: From October to December 2009, Beijing CDC conducted a serum survey of the novel influenza A (H1N1) in the local residents, stratified in 10 age groups between 5 years to over 60 years, without H1N1 vaccination history and disease history. Hemagglutination inhibition (HI) assays were performed at Beijing CDC. Statistical significance was determined with geometric mean titer (GMT).

RESULTS: 3499 serum samples were tested for HI antibody. The average level of HI antibody was 1:8.03, and 11.06% (387/3499) were sero-positive (HI antibody level ≥ 1:40). In the group aged from 5 to 19 years, the level of HI antibody and the sero-positive rate were higher (HI antibody > 1:8.9, sero-positive rate > 12%).

CONCLUSIONS: The antibody levels in different groups were affected by age specific morbidity, and the higher antibody level of the school-age group was correlated with higher disease intensity in this population. The data showed that the herd immunity in Beijing was under the optimal level, but influenza A (H1N1) would probably become prevalent in the short coming future.

PMID: 20979808 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20979808
 
Back
Top Bottom